Zoptarelin Doxorubicin

AEZS-108 (zoptarelin doxorubicin) · AEterna Zentaris

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zoptarelin Doxorubicin, covering 2018-07-31 to 2018-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer [Phase 3]